HALO · Halozyme Therapeutics, Inc. · Documents

$124.83 +0.46 (+0.37%) At close · Oct 21

Market Cap

$14.17B

113.50M

Volume · Oct 21 1.74M Avg daily vol (3M) 2.25M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
DEFA14A	—	2022-04-18	—
SC TO-C	—	2022-04-14	—
SC TO-C	—	2022-04-13	—
8-K	—	2022-04-13	2022-04-12
SC TO-C	—	2022-04-13	—
DEF 14A	—	2022-03-25	2021-12-31
DEFA14A	—	2022-03-25	—
8-K	—	2022-03-21	2022-03-16
8-K	—	2022-03-15	—
10-K	—	2022-02-22	2021-12-31
8-K	—	2022-02-22	—
8-K	—	2022-02-03	2022-02-02
8-K	—	2022-01-10	—
8-K	—	2021-12-29	2021-12-23
8-K	—	2021-12-13	—
8-K	—	2021-12-10	2021-12-08
8-K	—	2021-11-02	—
10-Q	—	2021-11-02	2021-09-30
8-K/A	—	2021-11-02	—
10-Q	—	2021-08-09	2021-06-30
8-K	—	2021-08-09	—
8-K	—	2021-05-10	—
10-Q	—	2021-05-10	2021-03-31
8-K	—	2021-05-07	2021-05-05
8-K	—	2021-05-05	—
8-K	—	2021-05-03	2021-05-01
DEF 14A	—	2021-03-26	2020-12-31
DEFA14A	—	2021-03-26	—
8-K	—	2021-03-01	—
8-K	—	2021-02-25	2021-02-24
10-K	—	2021-02-23	2020-12-31
8-K	—	2021-02-23	—
8-K	—	2021-02-23	—
8-K	—	2021-01-13	—
8-K	—	2021-01-11	—
10-Q	—	2020-11-02	2020-09-30
8-K	—	2020-11-02	—
8-K	—	2020-08-10	—
10-Q	—	2020-08-10	2020-06-30
10-Q	—	2020-05-11	2020-03-31
8-K	—	2020-05-11	—
8-K	—	2020-05-04	2020-04-30
DEFA14A	—	2020-04-03	—
DEF 14A	—	2020-03-20	2019-12-31
DEFA14A	—	2020-03-20	—
8-K	—	2020-02-24	—
10-K	—	2020-02-24	2019-12-31
8-K	—	2020-02-24	2020-02-18
8-K	—	2020-01-16	—
8-K	—	2020-01-14	—

Showing 101–150 of 150 filings

Key facts CIK 1159036 CUSIP 40637H109 13F (30d) 136 filings 133 filers Visit website Investor relations